Skip to main content
Erschienen in:

31.07.2024 | Invited Review

ESR Essentials: diagnostic work-up in patients with symptomatic breast disease—practice recommendations by the European Society of Breast Imaging

verfasst von: Alexandra Athanasiou, Linda Appelman, Ruud M. Pijnappel, Fiona J. Gilbert, Federica Pediconi, Ritse Mann

Erschienen in: European Radiology | Ausgabe 2/2025

Einloggen, um Zugang zu erhalten

Abstract

Breast complaints are frequent reasons for consultations in primary care or breast clinics. Breast pain, breast lumps, and nipple discharge are the most common complaints. Less common symptoms such as skin changes and axillary abnormalities also require specific diagnostic approaches. Imaging the symptomatic breast should be performed by appropriately trained breast radiologists following the best practice guidelines and quality standards. Full-field digital mammography (FFDM), digital breast tomosynthesis (DBT), and breast ultrasound (US) are the main modalities used in this primary setting. The choice depends on the patient’s age and symptoms. Women younger than 30-years-old are first imaged by US, whereas women over 40-years-old usually require both FFDM or DBT and US. For women between 30-years-old and 40-years-old, the US is the modality of choice, whereas FFDM or DBT might also be performed if needed. Pregnant or lactating women with palpable lesions or nipple discharge are imaged with US as the first method; FFDM or DBT can also be performed depending on the degree of suspicion as the dose to the fetus is minimal, and shielding may even further reduce the dose. More advanced techniques such as breast magnetic resonance imaging or contrast-enhanced mammography are not indicated in this first diagnostic setting and are reserved for cases of established malignancy (local staging) or rare cases of equivocal findings not otherwise resolved or inflammatory breast cancer. Last, but not least, male breast symptoms should also be addressed with US and/or FFDM.

Clinical relevance statement

It is equally important to correctly diagnose an underlying malignancy and to avoid false positives that would lead to unnecessary biopsies, increased costs, and anxiety for the patient. Proper use of imaging modalities ensures optimal diagnostic approach and minimizes false negatives.

Key Points

  • Ultrasound, full-field digital mammography, or digital breast tomosynthesis are the main imaging modalities in the diagnostic setting, while MRI or contrast-enhanced mammography should be reserved to selected cases.
  • Initial imaging modality includes ultrasound combined with mammography or digital breast tomosynthesis depending on women's age and the presence (or not) of inconclusive findings.
  • A negative imaging evaluation should not deter biopsy when a highly suspicious finding is found on physical examination.
Literatur
1.
Zurück zum Zitat Salzman B, Fleegle S, Tully AS (2012) Common breast problems. Am Fam Physician 86:343–349PubMed Salzman B, Fleegle S, Tully AS (2012) Common breast problems. Am Fam Physician 86:343–349PubMed
2.
Zurück zum Zitat Huggenberger IK, Andersen JS (2015) Predictive value of the official cancer alarm symptoms in general practice-a systematic review. Dan Med J 62:A5034PubMed Huggenberger IK, Andersen JS (2015) Predictive value of the official cancer alarm symptoms in general practice-a systematic review. Dan Med J 62:A5034PubMed
3.
Zurück zum Zitat Newell MS (2023) The power of the probe: targeted US alone for evaluation of breast symptoms. Radiology 307:e230418PubMed Newell MS (2023) The power of the probe: targeted US alone for evaluation of breast symptoms. Radiology 307:e230418PubMed
4.
Zurück zum Zitat Al Nemer A, Kussaibi H (2020) The accuracy of nipple discharge cytology in detecting breast cancer. Diagnosis 8:269–273PubMed Al Nemer A, Kussaibi H (2020) The accuracy of nipple discharge cytology in detecting breast cancer. Diagnosis 8:269–273PubMed
5.
Zurück zum Zitat Barsic Ostojic S, Grbanovic L, Tonklin A, Kovacevic L, Marusic Z, Prutki M (2022) Diagnostic performance of digital breast tomosynthesis in female patients with nipple discharge. Cancer Rep 5:e1602 Barsic Ostojic S, Grbanovic L, Tonklin A, Kovacevic L, Marusic Z, Prutki M (2022) Diagnostic performance of digital breast tomosynthesis in female patients with nipple discharge. Cancer Rep 5:e1602
6.
Zurück zum Zitat Evans A, Trimboli RM, Athanasiou A et al (2018) Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging 9:449–461PubMedPubMedCentral Evans A, Trimboli RM, Athanasiou A et al (2018) Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging 9:449–461PubMedPubMedCentral
7.
Zurück zum Zitat Liu N, Johnson KJ, Ma CX (2018) Male breast cancer: an updated surveillance, epidemiology, and end results data analysis. Clin Breast Cancer 18:e1602 Liu N, Johnson KJ, Ma CX (2018) Male breast cancer: an updated surveillance, epidemiology, and end results data analysis. Clin Breast Cancer 18:e1602
8.
Zurück zum Zitat Schorge J (2008) Breast disease. In: Schorge J, Schaffer J, Halvorson L, Hoffmann B, Bradshaw K, Cunningham F (eds) Williams gynecology. McGraw-Hill Medical, New York, pp 269–290 Schorge J (2008) Breast disease. In: Schorge J, Schaffer J, Halvorson L, Hoffmann B, Bradshaw K, Cunningham F (eds) Williams gynecology. McGraw-Hill Medical, New York, pp 269–290
11.
Zurück zum Zitat Leddy R, Irshad A, Zerwas E (2013) Role of breast ultrasound and mammography in evaluating patients presenting with focal breast pain in the absence of a palpable lump. Breast 19:582–589 Leddy R, Irshad A, Zerwas E (2013) Role of breast ultrasound and mammography in evaluating patients presenting with focal breast pain in the absence of a palpable lump. Breast 19:582–589
12.
Zurück zum Zitat Leung JW, Kornguth PJ, Gotway MB (2002) Utility of targeted sonography in the evaluation of focal breast pain. J Ultrasound Med 21:521–526PubMed Leung JW, Kornguth PJ, Gotway MB (2002) Utility of targeted sonography in the evaluation of focal breast pain. J Ultrasound Med 21:521–526PubMed
13.
Zurück zum Zitat Millet AV, Dirbas FM (2002) Clinical management of breast pain: a review. Obstet Gynecol Surv 57:451–461PubMed Millet AV, Dirbas FM (2002) Clinical management of breast pain: a review. Obstet Gynecol Surv 57:451–461PubMed
14.
Zurück zum Zitat Cho MW, Grimm LJ, Johnson KS (2017) Focal breast pain: Does breast density affect the need for ultrasound? Acad Radiol 24:53–59PubMed Cho MW, Grimm LJ, Johnson KS (2017) Focal breast pain: Does breast density affect the need for ultrasound? Acad Radiol 24:53–59PubMed
15.
Zurück zum Zitat Owen WA, Brazeal HA, Shaw HL, Lee MV, Appleton CM, Holley SO (2019) Focal breast pain: imaging evaluation and outcomes. Clin Imaging 55:148–155PubMed Owen WA, Brazeal HA, Shaw HL, Lee MV, Appleton CM, Holley SO (2019) Focal breast pain: imaging evaluation and outcomes. Clin Imaging 55:148–155PubMed
16.
Zurück zum Zitat Eberl MM, Phillips Jr RL, Lamberts H, Okkes I, Mahoney MC (2008) Characterizing breast symptoms in family practice. Ann Fam Med 6:528–533PubMedPubMedCentral Eberl MM, Phillips Jr RL, Lamberts H, Okkes I, Mahoney MC (2008) Characterizing breast symptoms in family practice. Ann Fam Med 6:528–533PubMedPubMedCentral
17.
Zurück zum Zitat Lehman CD, Lee AY, Lee CI (2014) Imaging management of palpable breast abnormalities. AJR Am J Roentgenol 203:1142–1153PubMed Lehman CD, Lee AY, Lee CI (2014) Imaging management of palpable breast abnormalities. AJR Am J Roentgenol 203:1142–1153PubMed
18.
Zurück zum Zitat Moy L, Slanetz PJ, Moore R, Satija S, Yeh ED, McCarthy KA (2002) Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review. Radiology 225:176–181PubMed Moy L, Slanetz PJ, Moore R, Satija S, Yeh ED, McCarthy KA (2002) Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review. Radiology 225:176–181PubMed
19.
Zurück zum Zitat Shetty MK, Shah YP (2002) Prospective evaluation of the value of negative sonographic and mammographic findings in patients with palpable abnormalities of the breast. J Ultrasound Med 21:1211–1216PubMed Shetty MK, Shah YP (2002) Prospective evaluation of the value of negative sonographic and mammographic findings in patients with palpable abnormalities of the breast. J Ultrasound Med 21:1211–1216PubMed
23.
Zurück zum Zitat Sardanelli F, Fallenberg EM, Clauser P et al (2017) Mammography: an update of the EUSOBI recommendations on information for women. Insights Imaging 8:11–18PubMed Sardanelli F, Fallenberg EM, Clauser P et al (2017) Mammography: an update of the EUSOBI recommendations on information for women. Insights Imaging 8:11–18PubMed
24.
Zurück zum Zitat Ciatto S, Houssami N, Bernardi D et al (2013) Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol 14:583–589PubMed Ciatto S, Houssami N, Bernardi D et al (2013) Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol 14:583–589PubMed
25.
Zurück zum Zitat Lång K, Andersson I, Rosso A, Tingberg A, Timberg P, Zackrisson S (2016) Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö breast tomosynthesis screening trial, a population-based study. Eur Radiol 26:184–190PubMed Lång K, Andersson I, Rosso A, Tingberg A, Timberg P, Zackrisson S (2016) Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö breast tomosynthesis screening trial, a population-based study. Eur Radiol 26:184–190PubMed
26.
Zurück zum Zitat Chan CH, Coopey SB, Freer PE, Hughes KS (2015) False-negative rate of combined mammography and ultrasound for women with palpable breast masses. Breast Cancer Res Treat 153:699–702PubMed Chan CH, Coopey SB, Freer PE, Hughes KS (2015) False-negative rate of combined mammography and ultrasound for women with palpable breast masses. Breast Cancer Res Treat 153:699–702PubMed
27.
Zurück zum Zitat Haas JS, Kaplan CP, Brawarsky P, Kerlikowske K (2005) Evaluation and outcomes of women with a breast lump and a normal mammogram result. J Gen Intern Med 20:692–696PubMedPubMedCentral Haas JS, Kaplan CP, Brawarsky P, Kerlikowske K (2005) Evaluation and outcomes of women with a breast lump and a normal mammogram result. J Gen Intern Med 20:692–696PubMedPubMedCentral
28.
Zurück zum Zitat Leung SE, Ben-Nachum I, Kornecki A (2016) New palpable breast lump with recent negative mammogram: Is repeat mammography necessary? AJR Am J Roentgenol 207:200–204PubMed Leung SE, Ben-Nachum I, Kornecki A (2016) New palpable breast lump with recent negative mammogram: Is repeat mammography necessary? AJR Am J Roentgenol 207:200–204PubMed
29.
Zurück zum Zitat Appelman L, Siebers CCN, Appelman PTM (2023) US and digital breast tomosynthesis in women with focal breast complaints: results of the breast US trial (BUST). Radiology 307:e220361PubMed Appelman L, Siebers CCN, Appelman PTM (2023) US and digital breast tomosynthesis in women with focal breast complaints: results of the breast US trial (BUST). Radiology 307:e220361PubMed
30.
Zurück zum Zitat Dodelzon K, Katzen JT (2019) Evaluation of palpable breast abnormalities. J Breast Imaging 1:253–263PubMed Dodelzon K, Katzen JT (2019) Evaluation of palpable breast abnormalities. J Breast Imaging 1:253–263PubMed
32.
Zurück zum Zitat Chung M, Hayward JH, Woodard GA, Knobel A et al (2020) US as the primary imaging modality in the evaluation of palpable breast masses in breastfeeding women, including those of advanced maternal age. Radiology. 297:316–324PubMed Chung M, Hayward JH, Woodard GA, Knobel A et al (2020) US as the primary imaging modality in the evaluation of palpable breast masses in breastfeeding women, including those of advanced maternal age. Radiology. 297:316–324PubMed
33.
Zurück zum Zitat Galati F, Magri V, Arias-Cadena PA, Moffa G (2023) Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge. Diagnostics 13:604PubMedPubMedCentral Galati F, Magri V, Arias-Cadena PA, Moffa G (2023) Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge. Diagnostics 13:604PubMedPubMedCentral
34.
Zurück zum Zitat Nissan N, Bauer E, Moss Massasa EE, Sklair-Levy M (2022) Breast MRI during pregnancy and lactation: clinical challenges and technical advances. Insights Imaging 13:71PubMedPubMedCentral Nissan N, Bauer E, Moss Massasa EE, Sklair-Levy M (2022) Breast MRI during pregnancy and lactation: clinical challenges and technical advances. Insights Imaging 13:71PubMedPubMedCentral
35.
Zurück zum Zitat Alghamdi Sr SA (2023) Gadolinium-based contrast agents in pregnant women: a literature review of MRI safety. Cureus 15:e38493PubMedPubMedCentral Alghamdi Sr SA (2023) Gadolinium-based contrast agents in pregnant women: a literature review of MRI safety. Cureus 15:e38493PubMedPubMedCentral
36.
Zurück zum Zitat Webb JA, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15:1234–1240PubMed Webb JA, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15:1234–1240PubMed
37.
Zurück zum Zitat Srinivasan A, Nia E, Gupta M, Sun J, Leung JW (2019) Retrospective statistical analysis on the diagnostic value of ductography based on lesion pathology in patients presenting with nipple discharge. Breast J 25:585–589PubMed Srinivasan A, Nia E, Gupta M, Sun J, Leung JW (2019) Retrospective statistical analysis on the diagnostic value of ductography based on lesion pathology in patients presenting with nipple discharge. Breast J 25:585–589PubMed
38.
Zurück zum Zitat Bahl M, Baker JA, Greenup RA, Ghate SV (2015) Diagnostic value of ultrasound in female patients with nipple discharge. AJR Am J Roentgenol 205:203–208PubMed Bahl M, Baker JA, Greenup RA, Ghate SV (2015) Diagnostic value of ultrasound in female patients with nipple discharge. AJR Am J Roentgenol 205:203–208PubMed
39.
40.
Zurück zum Zitat Bahl M, Baker JA, Greenup RA, Ghate SV (2015) Evaluation of pathologic nipple discharge: What is the added diagnostic value of MRI? Ann Surg Oncol 22:S435–S441PubMed Bahl M, Baker JA, Greenup RA, Ghate SV (2015) Evaluation of pathologic nipple discharge: What is the added diagnostic value of MRI? Ann Surg Oncol 22:S435–S441PubMed
41.
Zurück zum Zitat Berger N, Luparia A, Di Leo G (2017) Diagnostic performance of MRI versus galactography in women with pathologic nipple discharge: a systematic review and meta-analysis. AJR Am J Roentgenol 209:465–471PubMed Berger N, Luparia A, Di Leo G (2017) Diagnostic performance of MRI versus galactography in women with pathologic nipple discharge: a systematic review and meta-analysis. AJR Am J Roentgenol 209:465–471PubMed
42.
Zurück zum Zitat Elfgen C, Leo C, Kubik-Huch RA (2023) Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Virchows Arch 483:5–20PubMedPubMedCentral Elfgen C, Leo C, Kubik-Huch RA (2023) Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Virchows Arch 483:5–20PubMedPubMedCentral
43.
Zurück zum Zitat Rubio IT, Wyld L, Marotti L, Athanasiou A et al (2024) European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO. Eur J Surg Oncol 50:107292PubMed Rubio IT, Wyld L, Marotti L, Athanasiou A et al (2024) European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO. Eur J Surg Oncol 50:107292PubMed
44.
Zurück zum Zitat Menta A, Fouad TM, Lucci A (2018) Inflammatory breast cancer: What to know about this unique, aggressive breast cancer. Surg Clin North Am 98:787–800PubMed Menta A, Fouad TM, Lucci A (2018) Inflammatory breast cancer: What to know about this unique, aggressive breast cancer. Surg Clin North Am 98:787–800PubMed
45.
Zurück zum Zitat Yang WT, Le-Petross HT, Macapinlac H, Carkaci S et al (2008) Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 109:417–426PubMed Yang WT, Le-Petross HT, Macapinlac H, Carkaci S et al (2008) Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 109:417–426PubMed
46.
Zurück zum Zitat Papalouka V, Gilbert FJ (2018) Inflammatory breast cancer-importance of breast imaging. Eur J Surg Oncol 44:1135–1138PubMed Papalouka V, Gilbert FJ (2018) Inflammatory breast cancer-importance of breast imaging. Eur J Surg Oncol 44:1135–1138PubMed
47.
Zurück zum Zitat van Zelst JCM, Mann RM (2018) Automated three-dimensional breast US for screening: technique, artifacts, and lesion characterization. Radiographics 38:663–683PubMed van Zelst JCM, Mann RM (2018) Automated three-dimensional breast US for screening: technique, artifacts, and lesion characterization. Radiographics 38:663–683PubMed
48.
Zurück zum Zitat Boca Bene I, Ciurea AI, Ciortea CA, Dudea SM (2021) Pros and cons for automated breast ultrasound (ABUS): a narrative review. J Pers Med 11:703PubMedPubMedCentral Boca Bene I, Ciurea AI, Ciortea CA, Dudea SM (2021) Pros and cons for automated breast ultrasound (ABUS): a narrative review. J Pers Med 11:703PubMedPubMedCentral
49.
Zurück zum Zitat Liu N, Johnson KJ, Ma CX (2018) Male breast cancer: an updated surveillance, epidemiology, and end results data analysis. Clin Breast Cancer 18:e997–e1002PubMed Liu N, Johnson KJ, Ma CX (2018) Male breast cancer: an updated surveillance, epidemiology, and end results data analysis. Clin Breast Cancer 18:e997–e1002PubMed
Metadaten
Titel
ESR Essentials: diagnostic work-up in patients with symptomatic breast disease—practice recommendations by the European Society of Breast Imaging
verfasst von
Alexandra Athanasiou
Linda Appelman
Ruud M. Pijnappel
Fiona J. Gilbert
Federica Pediconi
Ritse Mann
Publikationsdatum
31.07.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2025
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-024-10980-5

Neu im Fachgebiet Radiologie

Ringen um den richtigen Umgang mit Zufallsbefunden

Wenn 2026 in Deutschland das Lungenkrebsscreening mittels Low-Dose-Computertomografie (LDCT) eingeführt wird, wird es auch viele Zufallsbefunde ans Licht bringen. Das birgt Chancen und Risiken.

Bald 5% der Krebserkrankungen durch CT verursacht

Die jährlich rund 93 Millionen CTs in den USA könnten künftig zu über 100.000 zusätzlichen Krebserkrankungen führen, geht aus einer Modellrechnung hervor. Damit würde eine von 20 Krebserkrankungen auf die ionisierende Strahlung bei CT-Untersuchungen zurückgehen.

Röntgen-Thorax oder LDCT fürs Lungenscreening nach HNSCC?

Personen, die an einem Plattenepithelkarzinom im Kopf-Hals-Bereich erkrankt sind, haben ein erhöhtes Risiko für Metastasen oder zweite Primärmalignome der Lunge. Eine Studie hat untersucht, wie die radiologische Überwachung aussehen sollte.

Statine: Was der G-BA-Beschluss für Praxen bedeutet

Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.